Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: Total population study of trends and discontinuation patterns 2006-2009

Acta Psychiatrica Scandinavica

Volumn 128, Issue 1, 2013, Pages 70-77

  Zetterqvist, J ^a   Asherson, P ^b   Halldner, L ^a   Langstrom N ^a   Larsson, H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; Pharmacoepidemiology; Psychostimulants; Treatment

Indexed keywords

AMPHETAMINE; ATOMOXETINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEALTH SERVICE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SWEDEN; TREND STUDY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; PREVALENCE; REGISTRIES; SEVERITY OF ILLNESS INDEX; SWEDEN; YOUNG ADULT;

EID: 84878930973     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12004     Document Type: Article

References (40)

1. Polanczyk G, De LIMA MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and meta regression analysis. Am J Psychiatry 2007;164:942-948.
2. Fayyad J, De Graaf R, Kessler R et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402-409.
3. Kessler RC, Adler L, Barkley R et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723.
4. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009;194:204-211.
5. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997;36:1036-1045.
6. Skounti M, Philalithis A, Galanakis E. Variations in prevalence of attention deficit hyperactivity disorder worldwide. Eur J Pediatr 2007;166:117-123.
7. Banaschewski T, Coghill D, Santosh P et al. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 2006;15:476-495.
8. Findling RL. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Clin Ther 2008;30:942-957.
9. Greenhill L, Kollins S, Abikoff H et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006;45:1284-1293.
10. Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 2004;43:559-567.
11. Molina BS, Hinshaw SP, Swanson JM et al. The MTA at 8years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009;48:484-500.
12. Murray DW, Arnold LE, Swanson J et al. A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). Curr Psychiatry Rep 2008;10:424-431.
13. Adler LA, Zimmerman B, Starr HL et al. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol 2009;29:239-247.
14. Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 2009;23:733-744.
15. Kooij SJ, Bejerot S, Blackwell A et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010;10:67.
16. Mccarthy S, Asherson P, Coghill D et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 2009;194:273-277.
17. Wettermark B, Hammar N, Fored CM et al. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726-735.
18. Sweden Medical Products Agency. Läkemedelsbehandling av ADHD - Bakgrundsdokumentation [Swedish]. Available from: http://www.lakemedelsverket.se/malgrupp/Halso---sjukvard/Behandlings--rekommendationer/Behandlingsrekommendation---listan/ADHD/.
19. Serfling RJ. Approximation theorems of mathematical statistics. New York: Wiley, 2002.
20. Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment for ADHD. J Atten Disord 2007;10:335-342.
21. Zoega H, Furu K, Halldorsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 2011;123:360-367.
22. Scheffler RM, Hinshaw SP, Modrek S, Levine P. The global market for ADHD medications. Health Aff (Millwood) 2007;26:450-457.
23. Zito JM, Safer DJ, De Jong-Van Den Berg LT et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2008;2:26.
24. Cox ER, Motheral BR, Henderson RR, Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14years old: results from a commercially insured US sample. Pediatrics 2003;111:237-243.
25. Hodgkins P, Sasane R, Meijer WM. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Ther 2011;33:188-203.
26. Knellwolf AL, Deligne J, Chiarotti F et al. Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol 2008;64:311-317.
27. Wong IC, Asherson P, Bilbow A et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health Technol Assess 2009;13:iii-iv.
28. Vitiello B. An international perspective on pediatric psychopharmacology. Int Rev Psychiatry 2008;20:121-126.
29. Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med 2010;122:184-191.
30. Christensen L, Sasane R, Hodgkins P, Harley C, Tetali S. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 2010;26:977-989.
31. Miller AR, Lalonde CE, Mcgrail KM. Children's persistence with methylphenidate therapy: a population-based study. Can J Psychiatry 2004;49:761-768.
32. Olfson M, Marcus S, Wan G. Stimulant dosing for children with ADHD: a medical claims analysis. J Am Acad Child Adolesc Psychiatry 2009;48:51-59.
33. Trip AM, Visser ST, Kalverdijk LJ, De Jong-Van Den Berg LT. Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006. Br J Clin Pharmacol 2009;67:466-468.
34. Biederman J, Petty CR, Evans M, Small J, Faraone SV. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHDPsychiatry Res 2010;177:299-304.
35. Biederman J, Petty CR, Monuteaux MC et al. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry 2010;167:409-417.
36. Biederman J, Petty CR, O'connor KB, Hyder LL, Faraone SV. Predictors of persistence in girls with attention deficit hyperactivity disorder: results from an 11-year controlled follow-up study. Acta Psychiatr Scand 2012;125:147-156.
37. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta analysis of follow-up studies. Psychol Med 2006;36:159-165.
38. Marcer H, Finlay F, Baverstock A. ADHD and transition to adult services--the experience of community paediatricians. Child Care Health Dev 2008;34:564-566.
39. Singh SP. Transition of care from child to adult mental health services: the great divide. Curr Opin Psychiatry 2009;22:386-390.
40. Taylor N, Fauset A, Harpin V. Young adults with ADHD: an analysis of their service needs on transfer to adult services. Arch Dis Child 2010;95:513-517.